How BESREMi® Works

difference
difference

How BESREMi® Works

BESREMi® is the only FDA-approved treatment indicated for PV that targets the source of the disease.

Now is the time

Wherever you are in your PV journey, it's important that you understand your treatment options. Consider talking with your doctor about a treatment that targets PV at its source.

Target the source

BESREMi is the only FDA-approved treatment indicated for PV that targets the bone marrow and may help control blood cell counts. That's what makes BESREMi different—it addresses the cause of PV.

targets the source

imgRed Blood Cell

imgWhite Blood Cell

imgPlatelet

An innovative approach

BESREMi® is not chemotherapy. It's an innovative, long-acting interferon that you take once every 2 weeks. After maintaining stable blood levels for 1 year, you may be able to take BESREMi once every 4 weeks.

bottom page lines